My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
BSE: 524164 | NSE: IOLCP | Pharmaceuticals & Drugs | Small Cap
1. Is IOL Chemicals And Pharmaceuticals Ltd a good quality company?
Past 10 year’s financial track record analysis by Moneyworks4me indicates that IOL Chemicals And Pharmaceuticals Ltd is a below average quality company.
2. Is IOL Chemicals And Pharmaceuticals Ltd undervalued or overvalued?
The key valuation ratios of IOL Chemicals And Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is IOL Chemicals And Pharmaceuticals Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of IOL Chemicals And Pharmaceuticals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 12.3% | - | ||
| Value Creation Index ⓘ | NA | NA | NA | NA | NA | NA | NA | NA | NA | -0.1 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,184 | 2,217 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - | ||
| Adj EPS ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.1 | 23.7 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - | ||
| BVPS (₹) ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 237.2 | 256.8 | ||
| Adj Net Profit ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 171 | 139 | ||
| Cash Flow from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93.1 | - | ||
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | NA | NA | NA | NA | ||||||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||||||
| BVPS ⓘ | 0 | 0 | 0 | 0 | ||||||||
| Share Price | 37.6% | 38.5% | 5.8% | 35.6% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.3 | 9.6 | |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.9 | 10.2 | |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.8 | 6.3 | |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 141 | |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71 | |
Return on Equity has increased versus last 3 years average to 9.60%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at 0.64%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 23.8 | 23.7 |
| TTM Sales (₹ Cr.) | 2,217 | 2,217 |
| BVPS (₹.) ⓘ | 256.6 | 256.8 |
| Reserves (₹ Cr.) ⓘ | 1,448 | 1,449 |
| P/BV ⓘ | 1.79 | 1.79 |
| PE ⓘ | 19.30 | 19.41 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 272.20 / 469.80 |
| All Time Low / High (₹) | 0.33 / 898.40 |
| Market Cap (₹ Cr.) | 2,701 |
| Equity (₹ Cr.) | 58.7 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 38.5 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike.
IOLCP has attained a front line position in the domestic segment and is thus contemplating to widen its horizon through global penetration. It has overseas customers from various countries like Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt and many others.
IOLCP is therefore moving ahead with its vision to develop global strategic alliances with quality leaders and expand into new markets.
Product range of the company includes:
Clientele:
They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, CIPLA, Flex Industries, ICI Paints, Asian Paints, Pidilite, Rallis India, Hindustan Polymide, Gujarat Super Phosphate, & Avon Organics etc.
Awards & Achievements:
Future Plans:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Download APP
